Login

Insider Transactions

What Orchard Therapeutics plc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 0

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Geraghty James A Director Jan 24 Disposition to Issuer · D −44,391 0
Thomas Frank E See Remarks Jan 24 Disposition to Issuer · D −92,081 0
Gaspar Bobby Chief Executive Officer Jan 24 Disposition to Issuer · D −366,158 0
Dunoyer Marc Director Jan 24 Disposition to Issuer · D −37,179 0
Beck Joanne T. Director Jan 24 Disposition to Issuer · D −9,294 0
Rowland Charles A Jr Director Jan 24 Disposition to Issuer · D −12,294 0
Thomas Frank E See Remarks Mar 10 Exercise / conversion · M +20,000 $0.46 +$9.18K 92,081
Thomas Frank E See Remarks Feb 09 Exercise / conversion · M +20,000 $0.46 +$9.18K 72,081
Thomas Frank E See Remarks Apr 01 Open-market buy · P +10,000 $0.75 +$7.47K 52,081
Gaspar Bobby Chief Executive Officer Apr 01 Open-market buy · P +15,000 $0.74 +$11.1K 366,158
Fmr Llc 10% owner Feb 19 Derivative Conversion · C −409,852 4,099,540
Fmr Llc 10% owner Feb 19 Derivative Conversion · C −409,852 4,099,540
Fmr Llc 10% owner Feb 05 Open-market sale · S −1,022,755 $6.98 −$7.14M 5,099,540
Fmr Llc 10% owner Feb 05 Open-market sale · S −1,022,755 $6.98 −$7.14M 5,099,540
Thomas Frank E See Remarks Jan 29 Exercise / conversion · M +10,000 $2.44 +$24.4K 42,081
Thomas Frank E See Remarks Jan 11 Withheld — tax / exercise cost · F −3,706 $6.72 −$24.9K 32,081
Gaspar Bobby Chief Executive Officer Jan 11 Withheld — tax / exercise cost · F −3,411 $6.72 −$22.9K 351,158
Thomas Frank E See Remarks Jan 08 Grant / award · A +10,667 35,787
Gaspar Bobby Chief Executive Officer Jan 08 Grant / award · A +6,250 354,569
Ra Capital MANAGEMENT, L.p. 10% owner Sep 24 Open-market buy · P +473,327 $4.61 +$2.18M 9,880,865

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support